Mechanism of Action of St. John's Wort
St. John's wort works primarily through inhibition of neurotransmitter reuptake (serotonin, norepinephrine, and dopamine) and is a strong inducer of cytochrome P450 isoenzyme 3A4 (CYP3A4), which is its most clinically significant mechanism from a safety perspective 1.
Primary Pharmacological Mechanisms
The antidepressant effects of St. John's wort involve multiple neurotransmitter systems:
Neurotransmitter Reuptake Inhibition
- Non-selective blockade of synaptosomal uptake of serotonin, dopamine, and norepinephrine with approximately equal affinity 2, 3
- This increases monoamine concentrations in the synaptic cleft, similar to conventional antidepressants 3
- The main pharmacologic effect resembles inhibition of reuptake mechanisms seen with standard antidepressants 4
Receptor Modulation
- Increases density of serotonergic (5-HT2) and dopaminergic receptors 2, 3
- Downregulates beta-adrenergic receptors in the frontal cortex 2
- Demonstrates affinity for GABA-A, GABA-B, adenosine, and glutamate receptors 2, 3
- Increases affinity for GABAergic receptors 3
Active Constituents
The therapeutic effects are attributed to multiple bioactive compounds 5, 2:
- Hypericin (naphthodianthrone): standardized to 0.12% to 0.28% in most clinical trials 6
- Hyperforin (phloroglucinol derivative): major contributor to antidepressant activity
- Flavonoids, biflavones, proanthocyanidines, xanthones
Clinically Critical Drug Interaction Mechanism
The most important mechanism for clinical practice is CYP3A4 induction 1. St. John's wort:
- Activates the pregnane X receptor (PXR), a ligand-activated transcription factor 7
- Induces CYP3A4, which metabolizes approximately 60% of all clinically relevant drugs 7
- Results in rapid drug elimination and reduced efficacy of co-administered medications
Contraindicated Combinations
St. John's wort is contraindicated with 1:
- Monoamine oxidase inhibitors (risk of serotonin syndrome)
- Serotonin reuptake inhibitors (risk of serotonin syndrome)
- Oral contraceptives (reduced bioavailability/efficacy)
- Immunosuppressants (reduced bioavailability/efficacy)
Additional Mechanisms
Neuroendocrine Effects
- Regulates genes controlling hypothalamic-pituitary-adrenal (HPA) axis function 2
- Protects against consequences of unavoidable stress in animal models 2
Other Actions
- Anti-inflammatory effects through multiple pathways 5
- Antioxidant properties 5
- Weak inhibition of monoamine oxidase-A and -B (not the primary mechanism) 2, 3
- May decrease platelet aggregation 4
Important Clinical Caveats
Quality control is a major concern: St. John's wort is not FDA-regulated, and there is no current standard for contents and potency 1. Patients in the United States may not reliably obtain preparations with similar effectiveness as those used in clinical trials 1.
The mechanism involves complex, dualistic modulation of neurotransmitter systems 5, making it difficult to predict individual responses. The interaction between multiple bioactive compounds creates a multifaceted pharmacological profile that differs from single-compound synthetic antidepressants.